Sethuraman Natarajan

CIK 00018733941 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001873394

Recent Transactions

47 trades

Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-09-02$5.43/sh−1,760→ 197,899 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-03-03$11.68/sh−6,138→ 199,659 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-03-01+60,800→ 205,797 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2025-03-01+90,800→ 90,800 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-12-03$20.15/sh−11,703→ 144,997 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-12-02$20.26/sh−4,088→ 156,700 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-29$20.00/sh−100→ 160,788 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-13$20.04/sh−2,700→ 160,888 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-11$20.01/sh−1,409→ 163,588 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-06$19.32/sh−2,745→ 164,997 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-06$18.71/sh−9,554→ 167,742 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-05$18.18/sh−5,171→ 177,296 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-11-04$18.02/sh−749→ 182,467 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-10-16$18.00/sh−600→ 183,216 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-09$15.09/sh−2,642→ 183,816 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-06$15.24/sh−600→ 186,458 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-05$15.13/sh−167→ 187,058 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-04$15.42/sh−955→ 187,225 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$16.93/sh−151→ 188,194 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$15.76/sh−469→ 188,345 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$17.70/sh−14→ 188,180 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-07-15$18.00/sh−638→ 188,814 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-07-12$18.00/sh−600→ 189,452 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-05-20$15.19/sh−9,675→ 190,052 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-05-17$15.14/sh−8,305→ 199,727 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-05-16$15.00/sh−1,000→ 208,032 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-05$12.28/sh−1,505→ 209,032 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-04$12.42/sh−347→ 210,951 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-04$13.37/sh−414→ 210,537 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-03-01+66,800→ 66,800 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-01+44,100→ 211,298 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-05$14.46/sh−449→ 167,198 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-01+14,200→ 167,647 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-09-01+21,500→ 21,500 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-07-11$18.04/sh−14,852→ 153,447 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-07-10$18.00/sh−3,026→ 168,299 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-04-17$18.00/sh−3,961→ 171,325 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-02$11.60/sh−1,058→ 189,486 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-01+14,200→ 175,286 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-01+28,400→ 190,544 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-03-01+43,000→ 43,000 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-03-01+21,500→ 21,500 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-01+5,794→ 162,144 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2022-07-01+34,763→ 34,763 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2022-03-01+69,525→ 69,525 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-03-01+11,588→ 156,350 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2021-10-28+243,639→ 243,639 total

Companies

Entrada Therapeutics, Inc.
President, Research & Develop.
$TRDA

Recent Filings

Address

C/O ENTRADA THERAPEUTICS, INC. ONE DESIGN CENTER PLACE, SUITE 17-500

BOSTON, MA, 02210

View on SEC.gov